Recommendations for treating stage I-III periodontitis in the Taiwanese population: A consensus report from the Taiwan Academy of Periodontology.

BACKGROUND/PURPOSE: Based on the fundamental of the S3-level clinical practice guideline (CPG) for treating stage I-III periodontitis developed by the European Federation of Periodontology (EFP), this consensus report aimed to develop treatment recommendations for treating periodontitis in the Taiwanese population. METHODS: The report was constructed by experts from the Taiwan Academy of Periodontology. The following topics were reviewed: (a) the prevalence of periodontitis in Asia and current status of treatment in Taiwan; (b) specific anatomical considerations for treating periodontitis in Asians; (d) educational and preventive interventions and supragingival plaque control; (d) subgingival instrumentation and adjunctive treatment; (e) surgical periodontal therapy; and (f) maintenance and supportive periodontal care. Recommendations were made according to the evidences from the EFP CPG, the published literature and clinical studies in Asians, and the expert opinions. RESULTS: The treatment recommendations for the Taiwanese population were generally in parallel with the EFP CPG, and extra cautions during treatment and maintenance phases were advised due to the anatomical variations, such as shorter root trunk, higher prevalence of supernumerary distolingual root and lingual bony concavity in mandibular posteriors, and thinner anterior labial plate, of the Asian population. CONCLUSION: The EFP CPG could be adopted for treating periodontitis and maintaining periodontal health of the Taiwanese population, and anatomical variations should be cautious when the treatment is delivered.

The influence of sinus membrane thickness upon membrane perforation during lateral window sinus augmentation.

OBJECTIVES: To investigate: (1) sinus membrane thickness in patients receiving lateral window sinus augmentation via cone-beam computed tomography (CBCT) and (2) the influence of Schneiderian membrane thickness upon membrane perforation during lateral window approach. MATERIAL AND METHODS: A total of 73 subjects with 81 sinus lift procedures between years 2010 and 2013 were recruited consequently. Each patient selected had CBCT images in initial and immediately after surgery. The values and correlation between variables of membrane thickness, perforation rate, membrane morphology, residual bone height, and elevated bone height were evaluated. RESULTS: The mean thickness of the Schneiderian membrane was 1.32 ± 0.87 mm. Perforation rate was lowest (7.14%) when membrane thickness was 1-1.5 mm. As membrane became thicker (≥2 mm) or thinner (<1 mm), the perforation rate increased abruptly. When examined the membrane thickness category, Class B (between ≥1 mm and <2 mm) had the lowest perforation rate. Statistically significant correlation was found between the perforation and the membrane thickness. The amount of the remaining bone height did not significantly correlate to the membrane thickness nor influence the membrane perforation. CONCLUSIONS: This study demonstrated that membrane thickness was related to the sinus perforation during lateral window sinus augmentation. The perforation rate was lowest when the membrane thickness was 1-1.5 mm.

Potential biomarkers in saliva for oral squamous cell carcinoma.

Sensitive and reliable early diagnostic markers for oral squamous cell carcinoma (OSCC) remain unavailable. Early identification of recurrence for OSCC is also a challenge. Unlike the other deep cancers, OSCC is located in oral cavity. The DNA, RNA, and protein derived from the living cancer cells and inflammatory cells then can be conveniently obtained from saliva. High-throughput genomic and proteomic approaches have been carried out to identify the potential biomarkers in body fluids such as saliva and blood for diagnosis and prognosis of OSCC. This article reviewed the recently identified biomarkers from saliva for OSCC. In addition, the biomarkers which have been correlated with OSCC tumor malignancy by molecular pathology analysis are also described. Finally, the potential biomarkers that have been demonstrated to associate with the malignant OSCC may be used for salivary screening for high-risk patients are suggested. This article may help to identify the potential biomarkers for screening and the molecular pathology analysis for high-risk patients of OSCC. Effective screening to identify high-risk patients can allow the clinician to provide the appropriate treatment without delay and to reduce the recurrence of OSCC.